百欧海文制药 BHVN
$14.48 +$0.58 (+4.17%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.58 +0.69%
开盘$14.23
昨收$13.90
当日区间$13.76 – $14.50
成交量2.92M
市值$2.19B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例94.6%+0.60 个百分点，较上季度
持仓机构数337-2 ，较上季度
内部人近期交易37次买入 / 9次卖出净买入
空头持仓比例11.85% 占流通股回补天数 9.2 · 截至 15 Oct 2026
卖空成交量占比24.1%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$9.98M（11个净流入日，9个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有34.4%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从12.08%降至11.85%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +1,446,859 | 1.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +1,164,539 | 0.9% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +7,359,891 | 5.1% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +2,152,024 | 2.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,988,178 | 8.7% |
| Rubric Capital Management LP | Hedge Fund | 2026/Q3 | +1,721,493 | 1.1% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +1,343,002 | 2.8% |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Mutual Fund | 2026/Q3 | +995,865 | 1.1% |
| Cormorant Asset Management, LP | Hedge Fund | 2026/Q3 | +850,000 | 1.7% |
| Bank of America Corporation | Public Company | 2026/Q3 | +721,765 | 0.9% |
| FMR | Mutual Fund | 2026/Q3 | +605,647 | 2.0% |
| Longaeva Partners L.P. | Mutual Fund | 2026/Q3 | +599,903 | 0.4% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +555,427 | 2.2% |
| Eversept Partners, L.P. | Hedge Fund | 2026/Q3 | +515,804 | 0.3% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +474,968 | 1.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | Kimberly Gentile | Senior Vice President of Clinical Operations | Other Derivative Acquisition | +1,000 | $12.34 | 1,000 |
| 5 Aug 2026 | Infinitum Asset Management, LLC | Initial Statement of Beneficial | +0 | – | 6,250,000 | |
| 8 Jul 2026 | Warren Volles | General Counsel & Chief Legal Officer | Initial Statement of Beneficial | +0 | – | 732,000 |
| 27 Apr 2026 | John Childs | Independent Director | Other Derivative Acquisition | +68,693 | $9.61 | 68,693 |
| 27 Apr 2026 | Julia Gregory | Independent Director | Other Derivative Acquisition | +68,693 | $9.61 | 68,693 |
| 27 Apr 2026 | Robert Hugin | Independent Director | Other Derivative Acquisition | +68,693 | $9.61 | 68,693 |
| 27 Apr 2026 | Gregory Bailey | Independent Director | Other Derivative Acquisition | +68,693 | $9.61 | 68,693 |
| 27 Apr 2026 | Michael Heffernan | Lead Independent Director | Other Derivative Acquisition | +68,693 | $9.61 | 68,693 |
| 27 Apr 2026 | Irina Antonijevic | Independent Director | Other Derivative Acquisition | +68,693 | $9.61 | 68,693 |
| 27 Apr 2026 | Kishan Mehta | Director | Other Derivative Acquisition | +68,693 | $9.61 | 68,693 |
| 16 Mar 2026 | Kishan Mehta | Director | Other Acquisition | +17,342 | – | 22,662 |
| 16 Mar 2026 | Kishan Mehta | Director | Other Disposition | -17,342 | – | 22,662 |
| 26 Feb 2026 | Matthew Buten | Chief Financial Officer | Other Derivative Acquisition | +175,000 | $11.52 | 175,000 |
| 26 Feb 2026 | Vladimir Coric | Chairperson & CEO | Other Derivative Acquisition | +550,000 | $11.52 | 550,000 |
| 26 Feb 2026 | Kimberly Gentile | Senior Vice President of Clinical Operations | Other Derivative Acquisition | +175,000 | $11.52 | 175,000 |
| 26 Feb 2026 | Bruce Car | Chief Innovation Officer | Other Derivative Acquisition | +175,000 | $11.52 | 175,000 |
| 26 Feb 2026 | George Clark | Vice President | Other Derivative Acquisition | +50,000 | $11.52 | 50,000 |
| 4 Jan 2026 | Matthew Buten | Chief Financial Officer | Derivative Exercise and Sale | -2,594 | $9.93 | 195,652 |
| 4 Jan 2026 | Matthew Buten | Chief Financial Officer | Derivative Exercise and Retained | +1,656 | – | 195,652 |
| 4 Jan 2026 | Vladimir Coric | Chairperson & CEO | Derivative Exercise and Sale | -7,430 | $9.93 | 3,849,354 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 17,899,310 | 11.9% | 9.2 |
| 30 Sep 2026 | 19,053,695 | 12.6% | 6.4 |
| 15 Sep 2026 | 20,449,005 | 13.5% | 6.5 |
| 31 Aug 2026 | 19,000,171 | 12.6% | 4.8 |
| 14 Aug 2026 | 17,819,010 | 11.8% | 10.4 |
| 31 Jul 2026 | 18,185,373 | 12.1% | 9.3 |
暂无评论——快来第一个聊聊 BHVN。